Skip to main content

Together we are beating cancer

Donate now

Chemicals

Showing 12 out of 43 results
The International Agency for Research on Cancer's (IARC's) website, seen on a phone and a computer.

The International Agency for Research on Cancer has evaluated the risks of two types of forever chemical. Here's what the evidence tells us. The International Agency for Research on Cancer has evaluated the risks of two types of forever chemical. Here's what the evidence tells us.

by Tim Gunn, Sophie Brooks | News | 11 December 2023

11 December 2023

Microscopic images of pleural fluid cytology of a small cell oat cell carcinoma
  • Health & Medicine
  • Science & Technology

10 ways we’ve influenced progress in lung cancer

From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 10 ways we have worked towards progress in lung cancer. From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 10 ways we have worked towards progress in lung cancer.

by Amy Warnock | In depth | 1 November 2023

1 November 2023

Left to right: Emma Colliver, Dr William Hill and Dr Emilia Lim

We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today.  We chatted to three researchers working on TRACERx, Dr Emilia Lim, Dr William Hill and Emma Colliver about their work, what a day in their lives looks like, and how their paths have led to where they are today. 

by Jacob Smith | Interview | 13 December 2022

13 December 2022

An image of a chest x-ray showing some signs of disease

Up to 14% of people with lung cancer in the UK have never smoked. New research funded by us reveals why non-smokers face delays in getting diagnosed with lung cancer Up to 14% of people with lung cancer in the UK have never smoked. New research funded by us reveals why non-smokers face delays in getting diagnosed with lung cancer

by Jacob Smith | In depth | 25 November 2022

25 November 2022

Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers... Charlie Swanton, our chief clinician, headed to the world’s most important climate change conference to talk about the links between pollution and lung cancer in never smokers...

by Phil Prime | In depth | 13 December 2021

13 December 2021

We don't always know why never-smokers develop lung cancer, but the data suggests that genetics play a role, as well as environmental or occupational exposures. We don't always know why never-smokers develop lung cancer, but the data suggests that genetics play a role, as well as environmental or occupational exposures.

by Katie Roberts | Analysis | 16 November 2018

16 November 2018

This entry is part 12 of 23 in the series Science Surgery

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease. A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

by Justine Alford | Analysis | 26 September 2017

26 September 2017

We look at new research measuring how much pollution we're exposed to on our commutes, particularly in London. We look at new research measuring how much pollution we're exposed to on our commutes, particularly in London.

by Rachel Orritt | Analysis | 3 March 2017

3 March 2017

Luck
  • Science & Technology
  • Health & Medicine

Why cancer is (still) more than just ‘bad luck’

New research has uncovered a possible explanation for why some cancers are more common than others, we explore the details. New research has uncovered a possible explanation for why some cancers are more common than others, we explore the details.

by Emma Smith | Analysis | 25 August 2016

25 August 2016